These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36326142)

  • 1. COVID-19-associated coagulopathy in children: A multicenter observational cohort study.
    Zabeida A; Winikoff R; Pelland-Marcotte MC; Charlebois J; Sabapathy C
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30079. PubMed ID: 36326142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19-induced coagulopathy: Experience, achievements, prospects.
    Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
    Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
    Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
    J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy.
    Mitchell WB; Davila J; Keenan J; Jackson J; Tal A; Morrone KA; Silver EJ; O'Brien S; Manwani D
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28975. PubMed ID: 33661561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboprophylaxis Outcome in Childhood SARS-CoV-2 Infection: A Single-Center Experience.
    Karimi M; Sanaei Dashti A; Haghpanah S; Mansoori Y; Zarei T; Amanati A; Bordbar M
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):e97-e102. PubMed ID: 36162044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2020 Nov; 40(11):1130-1151. PubMed ID: 33006163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation Abnormalities and Management in Hospitalized Pediatric Patients With COVID-19.
    Noni M; Koukou DM; Tritzali M; Kanaka-Gantenbein C; Michos A; Spoulou V
    Pediatr Infect Dis J; 2022 Jul; 41(7):570-574. PubMed ID: 35389967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
    Muthiah A; Ohnigian S; Reagan JL; Hsu A
    R I Med J (2013); 2022 Aug; 105(6):36-40. PubMed ID: 35881999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
    Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
    Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19.
    Farrar JE; Trujillo TC; Mueller SW; Beltran L; Nguyen C; Hassell K; Kiser TH
    J Thromb Thrombolysis; 2022 Feb; 53(2):446-453. PubMed ID: 34410561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
    Al-Samkari H; Gupta S; Leaf RK; Wang W; Rosovsky RP; Brenner SK; Hayek SS; Berlin H; Kapoor R; Shaefi S; Melamed ML; Sutherland A; Radbel J; Green A; Garibaldi BT; Srivastava A; Leonberg-Yoo A; Shehata AM; Flythe JE; Rashidi A; Goyal N; Chan L; Mathews KS; Hedayati SS; Dy R; Toth-Manikowski SM; Zhang J; Mallappallil M; Redfern RE; Bansal AD; Short SAP; Vangel MG; Admon AJ; Semler MW; Bauer KA; Hernán MA; Leaf DE;
    Ann Intern Med; 2021 May; 174(5):622-632. PubMed ID: 33493012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood.
    Kumar R; Rivkin MJ; Raffini L
    J Thromb Haemost; 2023 Sep; 21(9):2313-2326. PubMed ID: 37268064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation abnormalities & thromboprophylaxis in COVID-19.
    Jandial A; Gupta A; Malviya A; Agastam S; Kumar D
    Indian J Med Res; 2021 May&Jun; 153(5&6):606-618. PubMed ID: 34643567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption of a National Prophylactic Anticoagulation Guideline for Hospitalized Pregnant Women With COVID-19: Retrospective Cohort Study.
    Hwang YM; Piekos S; Sorensen T; Hood L; Hadlock J
    JMIR Public Health Surveill; 2023 Jul; 9():e45586. PubMed ID: 37311123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.
    Whitworth H; Sartain SE; Kumar R; Armstrong K; Ballester L; Betensky M; Cohen CT; Diaz R; Diorio C; Goldenberg NA; Jaffray J; Keegan J; Malone K; Randolph AG; Rifkin-Zenenberg S; Leung WS; Sochet A; Srivaths L; Zia A; Raffini L
    Blood; 2021 Jul; 138(2):190-198. PubMed ID: 33895804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-associated coagulopathy.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
    Dimakakos E; Gomatou G; Catalano M; Olinic DM; Spyropoulos AC; Falanga A; Maraveyas A; Liew A; Schulman S; Belch J; Gerotziafas G; Marschang P; Cosmi B; Spaak J; Syrigos K;
    Anticancer Res; 2022 Jul; 42(7):3261-3274. PubMed ID: 35790272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.